- Home
- HYI vs OSUR Comparison
HYI vs OSUR Comparison
Compare HYI & OSUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HYI
- OSUR
- Stock Information
- Founded
- HYI 2010
- OSUR 2000
- Country
- HYI United States
- OSUR United States
- Employees
- HYI N/A
- OSUR N/A
- Industry
- HYI Investment Managers
- OSUR Medical/Dental Instruments
- Sector
- HYI Finance
- OSUR Health Care
- Exchange
- HYI Nasdaq
- OSUR Nasdaq
- Market Cap
- HYI 270.2M
- OSUR 223.0M
- IPO Year
- HYI N/A
- OSUR 1986
- Fundamental
- Price
- HYI $11.98
- OSUR $3.08
- Analyst Decision
- HYI
- OSUR Hold
- Analyst Count
- HYI 0
- OSUR 1
- Target Price
- HYI N/A
- OSUR $3.00
- AVG Volume (30 Days)
- HYI 50.6K
- OSUR 779.0K
- Earning Date
- HYI 01-01-0001
- OSUR 08-05-2025
- Dividend Yield
- HYI 9.59%
- OSUR N/A
- EPS Growth
- HYI N/A
- OSUR N/A
- EPS
- HYI N/A
- OSUR N/A
- Revenue
- HYI N/A
- OSUR $161,626,000.00
- Revenue This Year
- HYI N/A
- OSUR N/A
- Revenue Next Year
- HYI N/A
- OSUR $6.20
- P/E Ratio
- HYI N/A
- OSUR N/A
- Revenue Growth
- HYI N/A
- OSUR N/A
- 52 Week Low
- HYI $10.99
- OSUR $2.36
- 52 Week High
- HYI $12.24
- OSUR $4.92
- Technical
- Relative Strength Index (RSI)
- HYI 62.03
- OSUR 60.74
- Support Level
- HYI $11.88
- OSUR $2.92
- Resistance Level
- HYI $12.00
- OSUR $3.08
- Average True Range (ATR)
- HYI 0.07
- OSUR 0.14
- MACD
- HYI 0.01
- OSUR 0.01
- Stochastic Oscillator
- HYI 81.58
- OSUR 98.55
About HYI Western Asset High Yield Defined Opportunity Fund Inc.
Western Asset High Yield Defined Opps. is a non-diversified, limited-term, closed-end management investment company. The company's investment objective is to provide high income and seek capital appreciation. It invests a majority of its net assets in a portfolio of high-yield corporate fixed-income securities issued or originated by U.S. or foreign public or private corporations and other business entities, with varying maturities.
About OSUR OraSure Technologies Inc.
OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.